Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...

A longtime FDA official who took over last month as the agency’s top drug regulator intends to retire.The departure of ...

Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...

The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set to retire just weeks after taking the ...

Food and Drug Administration'‌s newly appointed head of the drug evaluation ‌department, Richard Pazdur, is set to retire ...